StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Precision BioSciences's profit margin for the twelve months ending Jun 30, 2026 was -117.0%. For fiscal 2025 it was -133.4%, against 10.4% the year before. The highest annual figure on record is 10.4% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-133.4%−143.9
FY2024Dec 31, 202410.4%+136.3
FY2023Dec 31, 2023-125.8%+319.0
FY2022Dec 31, 2022-444.8%−418.3
FY2021Dec 31, 2021-26.5%+422.4
FY2020Dec 31, 2020-448.9%−31.2
FY2019Dec 31, 2019-417.6%+5.4
FY2018Dec 31, 2018-423.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-170.2%+70743.6
Q4 FY2025Dec 31, 202558.9%+2840.2
Q3 FY2025Sep 30, 2025-167476.9%−164625.4
Q2 FY2025Jun 30, 2025-130666.7%−130732.3
Q1 FY2025Mar 31, 2025-70913.8%−70962.6
Q4 FY2024Dec 31, 2024-2781.3%−2549.9
Q3 FY2024Sep 30, 2024-2851.6%−2790.0
Q2 FY2024Jun 30, 202465.6%+125.7
Q1 FY2024Mar 31, 202448.8%+334.3
Q4 FY2023Dec 31, 2023-231.4%+37.4
Q3 FY2023Sep 30, 2023-61.6%+263.6
Q2 FY2023Jun 30, 2023-60.1%+752.3
Q1 FY2023Mar 31, 2023-285.4%+563.8
Q4 FY2022Dec 31, 2022-268.8%+82.8
Q3 FY2022Sep 30, 2022-325.2%−278.3
Q2 FY2022Jun 30, 2022-812.4%−843.9
Q1 FY2022Mar 31, 2022-849.2%−734.9
Q4 FY2021Dec 31, 2021-351.6%−86.5
Q3 FY2021Sep 30, 2021-46.9%+306.4
Q2 FY2021Jun 30, 202131.5%+3065.0
Q1 FY2021Mar 31, 2021-114.3%+269.2
Q4 FY2020Dec 31, 2020-265.1%+55.6
Q3 FY2020Sep 30, 2020-353.3%+73.0
Q2 FY2020Jun 30, 2020-3033.5%−2672.8
Q1 FY2020Mar 31, 2020-383.5%+198.4
Q4 FY2019Dec 31, 2019-320.7%−8.1
Q3 FY2019Sep 30, 2019-426.4%−42.4
Q2 FY2019Jun 30, 2019-360.7%+270.4
Q1 FY2019Mar 31, 2019-581.9%+7.9
Q4 FY2018Dec 31, 2018-312.6%–
Q3 FY2018Sep 30, 2018-383.9%–
Q2 FY2018Jun 30, 2018-631.1%–
Q1 FY2018Mar 31, 2018-589.8%–

More Precision BioSciences figures

See a number that looks wrong?